Arrowhead Pharmaceuticals Inc (ARWR)
R&D Expense Growth
14.41%
Quarterly · Period ending:
ARWR R&D Expense Growth
Latest reported14.41%period ending
Latest reported14.41%period ending
ARWR Quarterly R&D Growth (QoQ) (0.00% → 14.41%)
Latest values, visible window
High-resolution chart · PNG
ARWR r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |